NCT00673881View on ClinicalTrials.gov

ABT-335 (Choline Fenofibrate) Reverse Cholesterol Transport (RCT) Study

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Dyslipidemia
Interventions
DRUG

choline fenofibrate

135 mg choline fenofibrate daily(oral, capsule)

Trial Locations (1)

60610

Radiant Research, 515 N State St, #2700, Chicago

Sponsors

Lead Sponsor

Radiant Research
All Listed Sponsors
lead

Radiant Research

OTHER

NCT00673881 - ABT-335 (Choline Fenofibrate) Reverse Cholesterol Transport (RCT) Study | Biotech Hunter | Biotech Hunter